Boston Scientific fights IRS over transfer pricing adjustments
December 16, 2011
Joe Dalton
Boston Scientific, a US medical technology company, has filed a petition to the US Tax Court in a fight against a $581 million transfer pricing adjustment from the IRS.
The IRS is unhappy with the transfer pricing of technology licence agreements between certain subsidiaries of Guidant Corporation, which is owned by Boston Scientific.
Sorry. You must be a subscriber to view this article. Alternatively, why not take a free trial? To subscribe and access this article immediately simply click here or call +44(0)207 779 8380.